Categories: News

BiomX Presenting at Two Upcoming Conferences in November

Jefferies London Healthcare Conference on November 18 – 19, 2021

2021 Phage Futures Congress Europe on November 23 – 24, 2021

NESS ZIONA, Israel, Nov. 17, 2021 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced upcoming presentations at the Jefferies London Healthcare Conference on November 18-19 and the 2021 Phage Futures Congress Europe on November 23-24.

   
Jefferies London Healthcare Conference – November 18-19, 2021
   
Date & Time: On-demand session will be available to conference attendees beginning
Thursday, November 18, 3:00 AM EST through November 19, 12:00 PM EST
Presenter:  Jonathan Solomon
Webcast Link:  Link
   
2021 Phage Futures Congress Europe – November 23-24, 2021
 
Presentation Title: “Nebulized Bacteriophage Therapy for Chromic Pseudomonas aeruginosa
Pulmonary Infections in CF Patients”
Date & Time: November 23, 11:30 AM CET, 5:30 AM EST
Location Brussels, Beligium
Presenter:  Myriam Golembo, Ph.D.
   

Live webcasts of the Jefferies London Healthcare Conference will be accessible through the Investors section of the Company’s website at https://ir.biomx.com/news-events/ir-calendar. Following the events, the webcasts will be archived on the BiomX website.

About BiomX Inc.

BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as target bacteria in the treatment of chronic diseases, such as cystic fibrosis, atopic dermatitis, inflammatory bowel disease, primary sclerosing cholangitis, and colorectal cancer. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.BiomX.com

BiomX Contacts

Investor Relations:
LifeSci Advisors, LLC
John Mullaly
(617)-698-9253
jmullaly@lifesciadvisors.com 

Staff

Recent Posts

Patients Searching “Best Plastic Surgeon in America” Are Traveling for Clarity and Planning – Gruber Plastic Surgery Expands Out-of-Town Resources for 2026

Updated Fly-In Program outlines virtual consultations, travel timelines, recovery planning, and follow-up care for out-of-town…

3 hours ago

Dr. Kunaal Jindal Sheds Light on His Signature Mommy Makeover, Which Includes his High Definition Tummy Tuck with Liposculpting and Breast Reshaping

A closer look at the artistry, technique, and philosophy behind Dr. Jindal's most sought-after transformation.…

3 hours ago

Attune to Support Poppy Health’s $39M ARPA-H BREATHE Project in the U.S. Schools

VIENNA, Va., Dec. 19, 2025 /PRNewswire/ -- Attune announced today that the company will play…

6 hours ago

Feel30 Launches Austin-Based Telehealth Platform for Evidence-Proven TRT & Integrated At-Home Phlebotomy Services

AUSTIN, Texas, Dec. 19, 2025 /PRNewswire/ -- Feel30 , a telehealth platform specializing in testosterone…

6 hours ago

LISA LING JOINS TENDERCARE AS CHIEF CAREGIVER ADVOCATE & ADVISOR

– Will help address the difficult realities sandwich generation caregivers face with family caregiving –NEW…

6 hours ago

TENDERCARE LAUNCHING NATIONAL FAMILY CAREGIVING INFRASTRUCTURE, PARTNERING WITH THE AGING LIFE CARE ASSOCIATION® AND SUPPORTING THE CMS GUIDE MODEL PROGRAM

tendercare partnering with ALCA to raise national caregiving and eldercare industry standards;Selected as CMS GUIDE…

6 hours ago